BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36264973)

  • 1. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
    Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
    ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.
    Koellhoffer EC; Mao C; Beiss V; Wang L; Fiering SN; Boone CE; Steinmetz NF
    Mol Pharm; 2022 Feb; 19(2):592-601. PubMed ID: 34978197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
    Beiss V; Mao C; Fiering SN; Steinmetz NF
    Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unique potency of Cowpea mosaic virus (CPMV)
    Shukla S; Wang C; Beiss V; Cai H; Washington T; Murray AA; Gong X; Zhao Z; Masarapu H; Zlotnick A; Fiering S; Steinmetz NF
    Biomater Sci; 2020 Sep; 8(19):5489-5503. PubMed ID: 32914796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves
    Shukla S; Wang C; Beiss V; Steinmetz NF
    ACS Nano; 2020 Mar; 14(3):2994-3003. PubMed ID: 32133838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
    Murray AA; Wang C; Fiering S; Steinmetz NF
    Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated Cowpea Mosaic Virus for In Situ Vaccination: Differential Efficacy of Formalin vs UV-Inactivated Formulations.
    Jung E; Mao C; Bhatia M; Koellhoffer EC; Fiering SN; Steinmetz NF
    Mol Pharm; 2023 Jan; 20(1):500-507. PubMed ID: 36399598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA.
    Jung E; Chung YH; Mao C; Fiering SN; Steinmetz NF
    Mol Pharm; 2023 Jul; 20(7):3589-3597. PubMed ID: 37294891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade.
    Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
    Wang C; Beiss V; Steinmetz NF
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cowpea Mosaic Virus and Natural Killer Cell Agonism for In Situ Cancer Vaccination.
    Koellhoffer EC; Steinmetz NF
    Nano Lett; 2022 Jul; 22(13):5348-5356. PubMed ID: 35713326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
    Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
    Nkanga CI; Steinmetz NF
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of a Plant Virus Immunotherapy Candidate for Peritoneal Metastatic Ovarian Cancer.
    Omole AO; Affonso de Oliveira JF; Sutorus L; Steinmetz NF
    ACS Pharmacol Transl Sci; 2024 Feb; 7(2):445-455. PubMed ID: 38357279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.
    Mao C; Beiss V; Fields J; Steinmetz NF; Fiering S
    Biomaterials; 2021 Aug; 275():120914. PubMed ID: 34126409
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Chariou PL; Beiss V; Ma Y; Steinmetz NF
    Mater Adv; 2021 Mar; 2(5):1644-1656. PubMed ID: 34368764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Situ Vaccination of Tumors Using Plant Viral Nanoparticles.
    Murray AA; Sheen MR; Veliz FA; Fiering SN; Steinmetz NF
    Methods Mol Biol; 2019; 2000():111-124. PubMed ID: 31148013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic trafficking of plant virus nanoparticles in mice via the oral route.
    Rae CS; Khor IW; Wang Q; Destito G; Gonzalez MJ; Singh P; Thomas DM; Estrada MN; Powell E; Finn MG; Manchester M
    Virology; 2005 Dec; 343(2):224-35. PubMed ID: 16185741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.
    Lizotte PH; Wen AM; Sheen MR; Fields J; Rojanasopondist P; Steinmetz NF; Fiering S
    Nat Nanotechnol; 2016 Mar; 11(3):295-303. PubMed ID: 26689376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus.
    Ortega-Rivera OA; Shukla S; Shin MD; Chen A; Beiss V; Moreno-Gonzalez MA; Zheng Y; Clark AE; Carlin AF; Pokorski JK; Steinmetz NF
    ACS Infect Dis; 2021 Nov; 7(11):3096-3110. PubMed ID: 34672530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.